GNRH1 and ovarian hyperstimulation syndrome: Studies have demonstrated that for DOR patients, a GnRH antagonist regimen can achieve similar clinical results as a GnRH agonist regimen, with shorter medication duration, more patient acceptability, and a decreased risk of OHSS (17).